LobbyingRosalind Franklin University of Medicine and Science lobbying by quarter
Rosalind Franklin University of Medicine and Science's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q3 2023; the issues it reports most are Budget/Appropriations and Education.
Rosalind Franklin University of Medicine and Science
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $10K | 2 |
| Q3 2024 | $10K | 2 |
| Q4 2024 | $10K | 2 |
| Q1 2025 | $10K | 2 |
| Q2 2025 | $10K | 2 |
| Q3 2025 | $0 | 2 |
| Q4 2025 | $0 | 2 |
| Q1 2026 | $0 | 2 |
| Q2 2026 | $0 | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$50K · 8 reports
- Education$0 · 3 reports
- Defense$0 · 2 reports
- Health issues$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES11 reports
- SENATE8 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Conafay Group | $50K | 9 quarters |
| In-houseRosalind Franklin University of Medicine and Science | $0 | 12 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| NICOLAOS KALLIERIS | Associate VP for Government Relations | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/05for Q2 | In-house | Under $5,000 |
| 07/20for Q2 | The Conafay Group | Under $5,000 |
| 04/20for Q1 | The Conafay Group | Under $5,000 |
| 01/20for Q4 2025 | The Conafay Group | Under $5,000 |
| 01/20for Q4 2025 | In-house | Under $5,000 |
| 01/20for Q1 | In-house | Under $5,000 |
| 25/10/20for Q3 2025 | The Conafay Group | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | Under $5,000 |
| 25/07/18for Q2 2025 | The Conafay Group | $10K |
| 25/06/17for Q2 2025 | In-house | Under $5,000 |
| 25/04/18for Q1 2025 | The Conafay Group | $10K |
| 25/04/17for Q1 2025 | In-house | Under $5,000 |
| 25/01/17for Q4 2024 | The Conafay Group | $10K |
| 25/01/16for Q4 2024 | In-house | Under $5,000 |
| 24/10/16for Q3 2024 | The Conafay Group | $10K |
| 24/10/15for Q3 2024 | In-house | Under $5,000 |
| 24/07/19for Q2 2024 | The Conafay Group | $10K |
| 24/07/16for Q4 2023 | In-house | Under $5,000 |
| 24/07/16for Q3 2023 | In-house | Under $5,000 |
| 24/07/16for Q2 2024 | In-house | Under $5,000 |